top of page

Neurotranslational Article Repository

This repository contains articles relevant to how cognitive neuroscience can inform clinical practice. Articles in the first section are explicitly written for clinician audiences. Articles in the second section are more along the lines of academic background which could, for the sufficiently interested clinician, or with translational collaboration, eventually inform clinical practice. Note that review articles and meta-analyses are color-coded in blueIf you have any other articles that you would like added to this repository, please send us the citation(s) in an email to nttrsig@gmail.com with 'Repository Articles' in the subject line. The repository can also be viewed as a google doc here.  

  1. How cognitive neuroscience can inform clinical practice

    • Mechanisms of symptoms and disease

      • Maletic, V., Robinson, M., Oakes, T., Iyengar, S., Ball, S. G., & Russell, J. (2007). Neurobiology of depression: an integrated view of key findings. International journal of clinical practice, 61(12), 2030–2040. https://doi.org/10.1111/j.1742-1241.2007.01602.x

      • Singh, M. K., & Gotlib, I. H. (2014). The neuroscience of depression: implications for assessment and intervention. Behaviour research and therapy, 62, 60–73. https://doi.org/10.1016/j.brat.2014.08.008

      • Mataix‐Cols, D., Pertusa, A., & Snowdon, J. (2011). Neuropsychological and neural correlates of hoarding: A practice‐friendly review. Journal of clinical psychology, 67(5), 467-476.

    • Mechanisms of treatment

      • Field, T.A., Beeson, E. T., Jones, L.K. (2015). The new ABC’s: A practitioner’s guide to neuroscience informed Cognitive Behavior Therapy, Journal of Mental Health Counseling, 37(3), 206-220.

      • Månsson, K.N.T., Lueken, U., & Frick, A. (2020). Enriching CBT by Neuroscience: Novel Avenues to Achieve Personalized Treatments. International Journal of Cognitive Therapy, 14, 182-195. https://doi.org/10.1007/s41811-020-00089-0.

      • Porto P.R., Oliveira, L., Mari, J., Volchan, E., Figueira, I., Ventura, P. (2009) Does Cognitive Behavioral Therapy Change the Brain? A Systematic Review of Neuroimaging in Anxiety Disorders, J Neuropsychiatry 21(2) 114-125

      • Jokic-Begic, N. (2010) Cognitive Behavioral Therapy and Neuroscience: Towards Closer Integration, Psychological Topics, 19(2), 235-254

      • Siegle, G.J. & Coan, J. (2018). Neuroscience relevant to core processes in psychotherapy. In Hayes, S. & Hofmann, S. Process Based CBT: The Science and Core Clinical Competencies of Cognitive Behavioral Therapy. New Harbinger Publications, Oakland, CA

      • Perera, T., George, M. S., Grammer, G., Janicak, P. G., Pascual-Leone, A., & Wirecki, T. S. (2016). The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain stimulation, 9(3), 336-346

      • Horn, S., Fisher, P., Pfeifer, J., Allen, N., & Berkman, E. (2020). Levers and Barriers to Success in the Use of Translational Neuroscience for the Prevention and Treatment of Mental Health and Promotion of Well-Being Across the Lifespan. Journal of Abnormal Psychology, 129(1), 38-48.

    • Neurocognitive interventions

      • De Raedt, R. (2020). Contributions from neuroscience to the practice of Cognitive Behaviour Therapy: Translational psychological science in service of good practice. Behaviour Research and Therapy, 105, 103545.

      • Mohlman, J. (Ed.), Deckersbach, T. (Ed.), Weissman, A. (Ed.). (2015). From Symptom to Synapse. New York: Routledge, https://doi.org/10.4324/9780203507131

  2. ​Academic background that, with some work, could become translational​

    • Mechanisms of symptoms and disease

      • Anxiety and Related Disorders

        • ​Andreescu, C., Mennin, D., Tudorascu, D., Sheu, L. K., Walker, S., Banihashemi, L., & Aizenstein, H. (2015). The many faces of anxiety-neurobiological correlates of anxiety phenotypes. Psychiatry Research: Neuroimaging, 234(1), 96-105.

        • Dunsmoor, J. E., & Paz, R. (2015). Fear generalization and anxiety: behavioral and neural mechanisms. Biological psychiatry, 78(5), 336-343.

        • Duval, E. R., Javanbakht, A., & Liberzon, I. (2015). Neural circuits in anxiety and stress disorders: a focused review. Therapeutics and clinical risk management, 11, 115.

        • Etkin, A., & Wager, T. D. (2007). Functional neuroimaging of anxiety: a meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia. American journal of Psychiatry, 164(10), 1476-1488.

        • Freitas-Ferrari, M. C., Hallak, J. E., Trzesniak, C., Santos Filho, A., Machado-de-Sousa, J. P., Chagas, M. H. N., ... & Crippa, J. A. S. (2010). Neuroimaging in social anxiety disorder: a systematic review of the literature. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34(4), 565-580.

        • Hilbert, K., Lueken, U., & Beesdo-Baum, K. (2014). Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: a systematic review. Journal of affective disorders, 158, 114-126.

        • Jacob, Y., Shany, O., Goldin, P. R., Gross, J. J., & Hendler, T. (2019). Reappraisal of interpersonal criticism in social anxiety disorder: a brain network hierarchy perspective. Cerebral Cortex, 29(7), 3154-3167.

        • Maron, E., & Nutt, D. (2017). Biological markers of generalized anxiety disorder. Dialogues in clinical neuroscience, 19(2), 147.

        • Taylor, J. M., & Whalen, P. J. (2015). Neuroimaging and anxiety: The neural substrates of pathological and non-pathological anxiety. Current psychiatry reports, 17(6), 49.

      • Depression

        • Disner, S. G., Beevers, C. G., Haigh, E. A., & Beck, A. T. (2011). Neural mechanisms of the cognitive model of depression. Nature Reviews Neuroscience, 12(8), 467-477.

        • Drysdale, A. T., Grosenick, L., Downar, J., Dunlop, K., Mansouri, F., Meng, Y., ... & Schatzberg, A. F. (2017). Resting-state connectivity biomarkers define neurophysiological subtypes of depression. Nature medicine, 23(1), 28-38.

        • Price, R. B., Gates, K., Kraynak, T. E., Thase, M. E., & Siegle, G. J. (2017). Data-driven subgroups in depression derived from directed functional connectivity paths at rest. Neuropsychopharmacology, 42(13), 2623-2632.

        • Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011). Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology, 36(12), 2375-2394.

        • Steiger, A., & Kimura, M. (2010). Wake and sleep EEG provide biomarkers in depression. Journal of psychiatric research, 44(4), 242-252.

        • Weinberg, A., Perlman, G., Kotov, R., & Hajcak, G. (2016). Depression and reduced neural response to emotional images: Distinction from anxiety, and importance of symptom dimensions and age of onset. Journal of abnormal psychology, 125(1), 26.

      • Obsessive-Compulsive Disorder and Related Disorder

        • Eng, G. K., Sim, K., & Chen, S. H. A. (2015). Meta-analytic investigations of structural grey matter, executive domain-related functional activations, and white matter diffusivity in obsessive compulsive disorder: an integrative review. Neuroscience & Biobehavioral Reviews, 52, 233-257.

        • Friedlander, L., & Desrocher, M. (2006). Neuroimaging studies of obsessive–compulsive disorder in adults and children. Clinical psychology review, 26(1), 32-49.

        • Graybiel, A. M., & Rauch, S. L. (2000). Toward a neurobiology of obsessive-compulsive disorder. Neuron, 28(2), 343-347.

        • Mataix‐Cols, D., Pertusa, A., & Snowdon, J. (2011). Neuropsychological and neural correlates of hoarding: A practice‐friendly review. Journal of clinical psychology, 67(5), 467-476.

        • Phillips, M. L., & Mataix-Cols, D. (2004). Patterns of Neural Response to Emotive Stimuli Distinguish the Different Symptom Dimensions of Obsessive-Compulsive Disorders. CNS spectrums, 9, 275-283

        • Robbins, T. W., Vaghi, M. M., & Banca, P. (2019). Obsessive-compulsive disorder: puzzles and prospects. Neuron, 102(1), 27-47.

      • Post-Traumatic Stress Disorder

        • Hayes, J. P., LaBar, K. S., Petty, C. M., McCarthy, G., & Morey, R. A. (2009). Alterations in the neural circuitry for emotion and attention associated with posttraumatic stress symptomatology. Psychiatry Research: Neuroimaging, 172(1), 7-15.

        • Kaczkurkin, A. N., Burton, P. C., Chazin, S. M., Manbeck, A. B., Espensen-Sturges, T., Cooper, S. E., ... & Lissek, S. (2017). Neural substrates of overgeneralized conditioned fear in PTSD. American Journal of Psychiatry, 174(2), 125-134.

        • Larson, C. L., deRoon-Cassini, T., Taubitz, L. E., & Belleau, E. L. (2014, September). Neural markers of emotion dysregulation in acute trauma survivors predict chronic PTSD. Symposium presentation at the annual meeting of the Society for Research in Psychopathology.

        • Shvil, E., Rusch, H. L., Sullivan, G. M., & Neria, Y. (2013). Neural, psychophysiological, and behavioral markers of fear processing in PTSD: a review of the literature. Current psychiatry reports, 15(5), 358.

      • Substance Use Disorders

        • Claus, E. D., Kiehl, K. A., & Hutchison, K. E. (2011). Neural and behavioral mechanisms of impulsive choice in alcohol use disorder. Alcoholism: Clinical and Experimental Research, 35(7), 1209-1219.

        • Everitt, B. J., Belin, D., Economidou, D., Pelloux, Y., Dalley, J. W., & Robbins, T. W. (2008). Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philosophical Transactions of the Royal Society B: Biological Sciences, 363(1507), 3125-3135.

        • Garavan, H., & Stout, J. C. (2005). Neurocognitive insights into substance abuse. Trends in cognitive sciences, 9(4), 195-201

        • Tessner, K. D., & Hill, S. Y. (2010). Neural circuitry associated with risk for alcohol use disorders. Neuropsychology review, 20(1), 1-20.

      • Transdiagnostic

        • ​McTeague, L. M., Huemer, J., Carreon, D. M., Jiang, Y., Eickhoff, S. B., & Etkin, A. (2017). Identification of common neural circuit disruptions in cognitive control across psychiatric disorders. American Journal of Psychiatry, 174(7), 676-685.

    • Mechanisms of treatment

      • Brooks, S. J., & Stein, D. J. (2015). A systematic review of the neural bases of psychotherapy for anxiety and related disorders. Dialogues in clinical neuroscience, 17(3), 261.

      • De Raedt, R. (2020). Contributions from neuroscience to the practice of Cognitive Behaviour Therapy: Translational psychological science in service of good practice. Behaviour Research and Therapy, 105, 103545.

      • DeRubeis, R. J., Siegle, G. J., & Hollon, S. D. (2008). Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nature Reviews Neuroscience, 9(10), 788-796.

      • Goodwin, G. M., Holmes, E. A., Andersson, E., Browning, M., Jones, A., Lass-Hennemann, J., ... & van Zutphen, L. (2018). From neuroscience to evidence based psychological treatments–The promise and the challenge, ECNP March 2016, Nice, France. European Neuropsychopharmacology, 28(2), 317-333.

      • Jokić-Begić, N. (2010). Cognitive-behavioral therapy and neuroscience: Towards closer integration. Psihologijske teme, 19(2), 235-254.

      • Klumpp, H., Fitzgerald, D. A., & Phan, K. L. (2013). Neural predictors and mechanisms of cognitive behavioral therapy on threat processing in social anxiety disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 45, 83-91.

      • Ritchey, M., Dolcos, F., Eddington, K. M., Strauman, T. J., & Cabeza, R. (2011). Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. Journal of psychiatric research, 45(5), 577-587.

      • Ruhé, H. G., Booij, J., Veltman, D. J., Michel, M. C., & Schene, A. H. (2012). Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. Journal of Clinical Psychiatry, 73(4), 451.

      • Schmidt, H. D., Shelton, R. C., & Duman, R. S. (2011). Functional biomarkers of depression: diagnosis, treatment, and pathophysiology. Neuropsychopharmacology, 36(12), 2375-2394.

      • Siegle, G.J. & Coan, J. (2018). Neuroscience relevant to core processes in psychotherapy. In Hayes, S. & Hofmann, S. Process Based CBT: The Science and Core Clinical Competencies of Cognitive Behavioral Therapy. New Harbinger Publications, Oakland, CA

      • Straub, J., Plener, P. L., Sproeber, N., Sprenger, L., Koelch, M. G., Groen, G., & Abler, B. (2015). Neural correlates of successful psychotherapy of depression in adolescents. Journal of affective disorders, 183, 239-246.

      • Thorsen, A. L., van den Heuvel, O. A., Hansen, B., & Kvale, G. (2015). Neuroimaging of psychotherapy for obsessive–compulsive disorder: a systematic review. Psychiatry Research: Neuroimaging, 233(3), 306-313.

      • Yoshimura, S., Okamoto, Y., Onoda, K., Matsunaga, M., Okada, G., Kunisato, Y., ... & Yamawaki, S. (2014). Cognitive behavioral therapy for depression changes medial prefrontal and ventral anterior cingulate cortex activity associated with self-referential processing. Social cognitive and affective neuroscience, 9(4), 487-493.

    • Mechanisms of individual differences in treatment success

      • Brehl, A. K., Kohn, N., Schene, A. H., & Fernández, G. (2020). A mechanistic model for individualised treatment of anxiety disorders based on predictive neural biomarkers. Psychological Medicine, 50(5), 727-736.

      • Doerig, N., Krieger, T., Altenstein, D., Schlumpf, Y., Spinelli, S., Späti, J., ... & Grosse Holtforth, M. (2016). Amygdala response to self-critical stimuli and symptom improvement in psychotherapy for depression. The British Journal of Psychiatry, 208(2), 175-181.

    • Identify biomarkers of treatment success

      • Depression​

        • Costafreda SG, Khanna A, Mourao-Miranda J, Fu CHY. Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression. Neuroreport. 2009 May 6;20(7):637–41.

        • Dichter, G. S., Felder, J. N., & Smoski, M. J. (2010). The effects of brief behavioral activation therapy for depression on cognitive control in affective contexts: an fMRI investigation. Journal of affective disorders, 126(1-2), 236-244.

        • Doerig, N., Krieger, T., Altenstein, D., Schlumpf, Y., Spinelli, S., Späti, J., ... & Grosse Holtforth, M. (2016). Amygdala response to self-critical stimuli and symptom improvement in psychotherapy for depression. The British Journal of Psychiatry, 208(2), 175-181.

        • Forbes, E. E., Olino, T. M., Ryan, N. D., Birmaher, B., Axelson, D., Moyles, D. L., & Dahl, R. E. (2010). Reward-related brain function as a predictor of treatment response in adolescents with major depressive disorder. Cognitive, Affective, & Behavioral Neuroscience, 10(1), 107-118.

        • Fu, C. H., Williams, S. C., Cleare, A. J., Scott, J., Mitterschiffthaler, M. T., Walsh, N. D., ... & Murray, R. M. (2008). Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biological psychiatry, 64(6), 505-512.

        • Klumpp, H., Fitzgerald, D. A., & Phan, K. L. (2013). Neural predictors and mechanisms of cognitive behavioral therapy on threat processing in social anxiety disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 45, 83-91.

        • Klumpp, H., Roberts, J., Kennedy, A. E., Shankman, S. A., Langenecker, S. A., Gross, J. J., & Phan, K. L. (2017). Emotion regulation related neural predictors of cognitive behavioral therapy response in social anxiety disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 75, 106-112.

        • Lueken, U., Zierhut, K. C., Hahn, T., Straube, B., Kircher, T., Reif, A., ... & Domschke, K. (2016). Neurobiological markers predicting treatment response in anxiety disorders: A systematic review and implications for clinical application. Neuroscience & Biobehavioral Reviews, 66, 143-162.

        • Ritchey, M., Dolcos, F., Eddington, K. M., Strauman, T. J., & Cabeza, R. (2011). Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. Journal of psychiatric research, 45(5), 577-587.

        • Ruhé, H. G., Booij, J., Veltman, D. J., Michel, M. C., & Schene, A. H. (2012). Successful pharmacologic treatment of major depressive disorder attenuates amygdala activation to negative facial expressions: a functional magnetic resonance imaging study. Journal of Clinical Psychiatry, 73(4), 451.

        • Siegle, G. J., Carter, C. S., & Thase, M. E. (2006). Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. American Journal of Psychiatry, 163(4), 735-738.

        • Siegle, G. J., Thompson, W. K., Collier, A., Berman, S. R., Feldmiller, J., Thase, M. E., & Friedman, E. S. (2012). Toward clinically useful neuroimaging in depression treatment: prognostic utility of subgenual cingulate activity for determining depression outcome in cognitive therapy across studies, scanners, and patient characteristics. Archives of General Psychiatry, 69(9), 913-924.

        • Spies, M., Kraus, C., Geissberger, N., Auer, B., Klöbl, M., Tik, M., ... & Kasper, S. (2017). Default mode network deactivation during emotion processing predicts early antidepressant response. Translational psychiatry, 7(1)

        • Straub, J., Plener, P. L., Sproeber, N., Sprenger, L., Koelch, M. G., Groen, G., & Abler, B. (2015). Neural correlates of successful psychotherapy of depression in adolescents. Journal of affective disorders, 183, 239-246.

        • Tymofiyeva, O., Yuan, J. P., Huang, C. Y., Connolly, C. G., Blom, E. H., Xu, D., & Yang, T. T. (2019). Application of machine learning to structural connectome to predict symptom reduction in depressed adolescents with cognitive behavioral therapy (CBT). NeuroImage: Clinical, 23, 101914.

        • Yoshimura, S., Okamoto, Y., Onoda, K., Matsunaga, M., Okada, G., Kunisato, Y., ... & Yamawaki, S. (2014). Cognitive behavioral therapy for depression changes medial prefrontal and ventral anterior cingulate cortex activity associated with self-referential processing. Social cognitive and affective neuroscience, 9(4), 487-493.

    • Neurocognitive interventions

      • EEG​

        • Schoenberg, P. L., & David, A. S. (2014). Biofeedback for psychiatric disorders: a systematic review. Applied psychophysiology and biofeedback, 39(2), 109-135.           

        • Schoenberg, P. L., Sierra, M., & David, A. S. (2012). Psychophysiological investigations in depersonalization disorder and effects of electrodermal biofeedback. Journal of trauma & dissociation, 13(3), 311-329.

        • Sokhadze, T. M., Cannon, R. L., & Trudeau, D. L. (2008). EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research. Applied psychophysiology and biofeedback, 33(1), 1-28.

      • tDCS

        • Brunoni, A. R., Ferrucci, R., Bortolomasi, M., Vergari, M., Tadini, L., Boggio, P. S., ... & Priori, A. (2011). Transcranial direct current stimulation (tDCS) in unipolar vs. bipolar depressive disorder. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 35(1), 96-101

        • Kekic, M., Boysen, E., Campbell, I. C., & Schmidt, U. (2016). A systematic review of the clinical efficacy of transcranial direct current stimulation (tDCS) in psychiatric disorders. Journal of Psychiatric Research, 74, 70-86.

        • Tortella, G., Casati, R., Aparicio, L. V., Mantovani, A., Senço, N., D’Urso, G., ... & Junior, B. D. S. P. (2015). Transcranial direct current stimulation in psychiatric disorders. World journal of psychiatry, 5(1), 88.

      • TMS

        • Aleman, A. (2013). Use of repetitive transcranial magnetic stimulation for treatment in psychiatry. Clinical Psychopharmacology and Neuroscience, 11(2), 53.

        • Gorelick, D. A., Zangen, A., & George, M. S. (2014). Transcranial magnetic stimulation (TMS) in the treatment of substance addiction. Annals of the New York Academy of Sciences, 1327(1), 79.

        • Guo, Q., Li, C., & Wang, J. (2017). Updated review on the clinical use of repetitive transcranial magnetic stimulation in psychiatric disorders. Neuroscience bulletin, 33(6), 747-756.

        • Kim, D. R., Pesiridou, A., & O’Reardon, J. P. (2009). Transcranial magnetic stimulation in the treatment of psychiatric disorders. Current psychiatry reports, 11(6), 447-452.

        • Lisanby, S. H., Kinnunen, L. H., & Crupain, M. J. (2002). Applications of TMS to therapy in psychiatry. Journal of Clinical Neurophysiology, 19(4), 344-360.

        • Perera, T., George, M. S., Grammer, G., Janicak, P. G., Pascual-Leone, A., & Wirecki, T. S. (2016). The clinical TMS society consensus review and treatment recommendations for TMS therapy for major depressive disorder. Brain stimulation, 9(3), 336-346

        • Radhu, N., de Jesus, D. R., Ravindran, L. N., Zanjani, A., Fitzgerald, P. B., & Daskalakis, Z. J. (2013). A meta-analysis of cortical inhibition and excitability using transcranial magnetic stimulation in psychiatric disorders. Clinical Neurophysiology, 124(7), 1309-1320.

    • Neuroeducation

      • Field, T. A., Beeson, E. T., & Jones, L. K. (2016). Neuroscience-informed cognitive-behavior therapy in clinical practice: A preliminary study. Journal of Mental Health Counseling, 38(2), 139-154.​

    • Augmenting existing interventions

      • Field, T. A., Beeson, E. T., & Jones, L. K. (2016). Neuroscience-informed cognitive-behavior therapy in clinical practice: A preliminary study. Journal of Mental Health Counseling, 38(2), 139-154.

      • Hofmann, S. G., Fang, A., & Gutner, C. A. (2014). Cognitive enhancers for the treatment of anxiety disorders. Restorative neurology and neuroscience, 32(1), 183-195.

      • Vinograd, M., & Craske, M. G. (2020). Using neuroscience to augment behavioral interventions for depression. Harvard Review of Psychiatry, 28(1), 14-25.

Mech symptoms 1
Academic background - Mechanisms of symptoms
Mechanisms of treatment
Neurocognitve interventions
Academic - Mechanisms of treatment
Academic - Mechanisms of individual differences in tretment success
Academic - Identify biomarkers of treatment success
Academic - Neurocognitive interventions
Academic - Neuroeducation
bottom of page